Psychedelic medicine pioneer exits MDMA biotech after regulatory blow UK homepage

Psychedelic medicine pioneer exits MDMA biotech after regulatory blow Doblin leaves Lykos Therapeutics board after work on treatment for PTSD suffered setback from FDA ruling UK homepage August 15, 2024 at 11:29PM